The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
Flexible Solutions to Speed Your Molecules to Phase I Clinical Trials
Webinar On Demand
When developing new pharmaceutical products, it is very important to get to Phase I clinical trial in a fast, efficient and cost-effective way.
With Quick to Clinic™ for Oral Solid Dose, Thermo Fisher Scientific can deliver a drug in a phase-appropriate formulation for first-in-human studies in as little as 14 weeks from API receipt to release to clinic. This process includes one-month stability testing data to help complete regulatory submissions.
Watch this webcast to learn how to address early clinical development challenges, and how Thermo Fisher Scientific’s Quick to Clinic™ for Oral Solid Dose can help with:
- Speed and flexibility around formulation, manufacture, and clinical labeling/packaging/distribution
- Cost and time reduction
- Ensuring quality for first-in-human studies